Francisco Prado-Prado
Title
Cited by
Cited by
Year
Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of …
FJ Prado-Prado, H González-Díaz, OM de la Vega, FM Ubeira, KC Chou
Bioorganic & medicinal chemistry 16 (11), 5871-5880, 2008
2232008
Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach
H González-Díaz, F Prado-Prado, FM Ubeira
Current topics in medicinal chemistry 8 (18), 1676-1690, 2008
1752008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species
FJ Prado-Prado, X García-Mera, H González-Díaz
Bioorganic & medicinal chemistry 18 (6), 2225-2231, 2010
1292010
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug–drug complex networks
FJ Prado-Prado, OM de la Vega, E Uriarte, FM Ubeira, KC Chou, ...
Bioorganic & medicinal chemistry 17 (2), 569-575, 2009
1282009
Unified QSAR and network‐based computational chemistry approach to antimicrobials, part 1: Multispecies activity models for antifungals
H GonzÁlez‐DÍaz, FJ Prado‐Prado
Journal of computational chemistry 29 (4), 656-667, 2008
1202008
MIND-BEST: Web Server for Drugs and Target Discovery; Design, Synthesis, and Assay of MAO-B Inhibitors and Theoretical− Experimental Study of G3PDH Protein from Trichomonas …
H González-Díaz, F Prado-Prado, X García-Mera, N Alonso, P Abeijón, ...
Journal of proteome research 10 (4), 1698-1718, 2011
952011
Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers
H Gonzalez-Diaz, A Duardo-Sanchez, F M Ubeira, F Prado-Prado, ...
Current drug metabolism 11 (4), 379-406, 2010
942010
Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance
FJ Prado-Prado, H González-Díaz, L Santana, E Uriarte
Bioorganic & medicinal chemistry 15 (2), 897-902, 2007
892007
Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins
R Concu, MA Dea-Ayuela, LG Perez-Montoto, F Bolas-Fernández, ...
Journal of proteome research 8 (9), 4372-4382, 2009
852009
3D entropy and moments prediction of enzyme classes and experimental-theoretic study of peptide fingerprints in Leishmania parasites
R Concu, MA Dea-Ayuela, LG Perez-Montoto, FJ Prado-Prado, E Uriarte, ...
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1794 (12), 1784-1794, 2009
782009
Multi-target spectral moments for QSAR and complex networks study of antibacterial drugs
FJ Prado-Prado, E Uriarte, F Borges, H González-Díaz
European journal of medicinal chemistry 44 (11), 4516-4521, 2009
772009
Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species
H González-Díaz, FJ Prado-Prado, L Santana, E Uriarte
Bioorganic & medicinal chemistry 14 (17), 5973-5980, 2006
772006
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications and legal issues
H Gonzalez-Diaz, F Romaris, A Duardo-Sanchez, L G Perez-Montoto, ...
Current pharmaceutical design 16 (24), 2737-2764, 2010
732010
Trypano-PPI: A web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein− protein interactions
Y Rodriguez-Soca, CR Munteanu, J Dorado, A Pazos, FJ Prado-Prado, ...
Journal of proteome research 9 (2), 1182-1190, 2010
722010
ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen
E Tenorio-Borroto, CGP Rivas, JCV Chagoyán, N Castañedo, ...
Bioorganic & medicinal chemistry 20 (20), 6181-6194, 2012
672012
Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica
F Prado-Prado, X García-Mera, P Abeijón, N Alonso, O Caamaño, ...
European journal of medicinal chemistry 46 (4), 1074-1094, 2011
612011
2D MI-DRAGON: a new predictor for protein–ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human …
F Prado-Prado, X García-Mera, M Escobar, E Sobarzo-Sánchez, M Yañez, ...
European journal of medicinal chemistry 46 (12), 5838-5851, 2011
602011
Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species
FJ Prado-Prado, F Borges, LG Perez-Montoto, H González-Díaz
European journal of medicinal chemistry 44 (10), 4051-4056, 2009
572009
NL MIND-BEST: A web server for ligands and proteins discovery—Theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum
H González-Díaz, F Prado-Prado, E Sobarzo-Sanchez, M Haddad, ...
Journal of theoretical biology 276 (1), 229-249, 2011
532011
New Markov–Shannon Entropy models to assess connectivity quality in complex networks: From molecular to cellular pathway, Parasite–Host, Neural, Industry, and Legal–Social networks
P Riera-Fernandez, CR Munteanu, M Escobar, F Prado-Prado, ...
Journal of theoretical biology 293, 174-188, 2012
522012
The system can't perform the operation now. Try again later.
Articles 1–20